BACKGROUND AND PURPOSE: Most intramedullary astrocytomas have been known to exhibit at least some enhancement on MR imaging regardless of cell type or tumor grade. The purpose of this study was to evaluate the incidence of nonenhancing intramedullary astrocytomas through a retrospective study within our institutions and a systematic review of the medical literature. MATERIALS AND METHODS: A total of 19 consecutive patients (male to female ratio, 11:8; mean age, 27.84 +/- 19.0 years) with primary intramedullary astrocytomas Q WHO grade 1, 13 WHO grade 11, 3 WHO grade 111) who underwent preoperative MR imaging with contrast enhancement were included in this retrospective study from 4 institutions. The tumor-enhancement patterns were classifie...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
INTRODUCTION: Pilocytic astrocytoma (PA) is classified by the World Health Organization as a grade I...
The MR examinations in 25 patients with intramedullary tumors were analyzed. Seven patients were dia...
Abstract Background The purpose of this retrospective review is to determine the MR imaging features...
INTRODUCTION: Gemistocytic astrocytoma is the second most common subtype of World Health Organizatio...
Intramedullary astrocytomas (IMAs) are rare tumors, and few studies specific to the molecular altera...
Background: Tumors of the spinal cord or canal constitute approximately 15% to 20% of central nervou...
of the conus medullaris in a child. MR imaging showed at the T12-L1 level an intramedullary mass wit...
PURPOSE: To determine the biologic behavior and prognostic factors of spinal cord astrocytoma, we re...
Primitive IMT represent 8-10% of all primary tumors of the spinal cord. Only 2-4% of all CNS tumors ...
SUMMARY: Spinal cord astrocytomas are rare neoplasms that can result in alteration of the spinal cor...
BACKGROUND AND PURPOSE: Pilomyxoid astrocytoma (PMA) is a recently described variant of pilo-cytic a...
Background: Tumors within the cord are referred to as intramedullary and account for 10-15% of spina...
BACKGROUND AND PURPOSE: Pilomyxoid astrocytoma (PMA) is a recently described tumor that typically oc...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
INTRODUCTION: Pilocytic astrocytoma (PA) is classified by the World Health Organization as a grade I...
The MR examinations in 25 patients with intramedullary tumors were analyzed. Seven patients were dia...
Abstract Background The purpose of this retrospective review is to determine the MR imaging features...
INTRODUCTION: Gemistocytic astrocytoma is the second most common subtype of World Health Organizatio...
Intramedullary astrocytomas (IMAs) are rare tumors, and few studies specific to the molecular altera...
Background: Tumors of the spinal cord or canal constitute approximately 15% to 20% of central nervou...
of the conus medullaris in a child. MR imaging showed at the T12-L1 level an intramedullary mass wit...
PURPOSE: To determine the biologic behavior and prognostic factors of spinal cord astrocytoma, we re...
Primitive IMT represent 8-10% of all primary tumors of the spinal cord. Only 2-4% of all CNS tumors ...
SUMMARY: Spinal cord astrocytomas are rare neoplasms that can result in alteration of the spinal cor...
BACKGROUND AND PURPOSE: Pilomyxoid astrocytoma (PMA) is a recently described variant of pilo-cytic a...
Background: Tumors within the cord are referred to as intramedullary and account for 10-15% of spina...
BACKGROUND AND PURPOSE: Pilomyxoid astrocytoma (PMA) is a recently described tumor that typically oc...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
Intramedullary spinal tumors are uncommon intra-axial lesions, which can be either primary or metast...
INTRODUCTION: Pilocytic astrocytoma (PA) is classified by the World Health Organization as a grade I...